T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
1-800-Flowers.com
FLWS
$262M
| $64K | ﹤0.01% |
12,849
-9,748
| -43% | -$50.5K |
|
|
VOXR
2952
Vox Royalty Corp
VOXR
$356M
| $64K | ﹤0.01% |
+20,228
| New | +$66.7K |
|
|
CD
2953
Chaince Digital Holdings
CD
$454M
| $63K | ﹤0.01% |
+16,137
| New | +$81.3K |
|
2954
Avita Medical
RCEL
$251M
| $63K | ﹤0.01% |
11,869
+248
| +2% | +$1.8K |
|
2955
Larimar Therapeutics
LRMR
$454M
| $62K | ﹤0.01% |
21,301
+4,991
| +31% | +$11.6K |
|
2956
Mercer International
MERC
$32.3M
| $62K | ﹤0.01% |
17,659
-464
| -3% | -$1.92K |
|
|
STLN
2957
Starling Oncology, Inc. Common Stock
STLN
$644M
| $62K | ﹤0.01% |
+29,764
| New | +$74.4K |
|
2958
Chegg
CHGG
$88.9M
| $61K | ﹤0.01% |
50,086
-41,247
| -45% | -$38.1K |
|
|
NB
2959
NioCorp Developments
NB
$760M
| $61K | ﹤0.01% |
+26,104
| New | +$65.1K |
|
2960
Vivid Seats
SEAT
$81.6M
| $61K | ﹤0.01% |
1,779
+39
| +2% | +$1.67K |
|
|
AISP
2961
Airship AI Holdings
AISP
$71.3M
| $60K | ﹤0.01% |
+10,109
| New | +$45K |
|
|
BGFV
2962
DELISTED
Big 5 Sporting Goods
BGFV
| $60K | ﹤0.01% |
41,803
-1,097
| -3% | -$1.18K |
|
2963
Biote Corp
BTMD
$40.7M
| $60K | ﹤0.01% |
14,822
+4,113
| +38% | +$15.2K |
|
2964
Inhibikase Therapeutics
IKT
$377M
| $60K | ﹤0.01% |
+30,606
| New | +$59.9K |
|
2965
Energy Vault
NRGV
$710M
| $60K | ﹤0.01% |
83,900
-44,538
| -35% | -$36K |
|
2966
Willamette Valley Vineyards
WVVI
$11.5M
| $60K | ﹤0.01% |
10,850
| – | – |
|
2967
Outdoor Holding Co
POWW
$267M
| $59K | ﹤0.01% |
45,440
+6,466
| +17% | +$10.3K |
|
2968
Critical Metals Corp
CRML
$971M
| $59K | ﹤0.01% |
+16,260
| New | +$29.6K |
|
2969
Westwater Resources
WWR
$81M
| $58K | ﹤0.01% |
96,373
-2,527
| -3% | -$1.33K |
|
|
RPT
2970
Rithm Property Trust
RPT
$99.9M
| $58K | ﹤0.01% |
+3,546
| New | +$57.7K |
|
2971
Riverview Bancorp
RVSB
$106M
| $57K | ﹤0.01% |
+10,324
| New | +$59.7K |
|
2972
SunPower Inc
SPWR
$46.4M
| $57K | ﹤0.01% |
+30,489
| New | +$52.6K |
|
2973
CareCloud
CCLD
$104M
| $56K | ﹤0.01% |
23,700
| – | – |
|
2974
Clarus
CLAR
$141M
| $56K | ﹤0.01% |
15,947
+3,878
| +32% | +$13.1K |
|
2975
Design Therapeutics
DSGN
$917M
| $55K | ﹤0.01% |
16,314
+3,245
| +25% | +$12.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.